Faculty Opinions recommendation of Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.

Author(s):  
Salim Khakoo
2002 ◽  
Vol 76 (14) ◽  
pp. 6919-6928 ◽  
Author(s):  
P. André ◽  
F. Komurian-Pradel ◽  
S. Deforges ◽  
M. Perret ◽  
J. L. Berland ◽  
...  

ABSTRACT The presence of hepatitis C virus (HCV) RNA-containing particles in the low-density fractions of plasma has been associated with high infectivity. However, the nature of circulating HCV particles and their association with immunoglobulins or lipoproteins as well as the characterization of cell entry have all been subject to conflicting reports. For a better analysis of HCV RNA-containing particles, we quantified HCV RNA in the low-density fractions of plasma corresponding to the very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, and low-density lipoprotein (LDL) fractions from untreated chronically HCV-infected patients. HCV RNA was always found in at least one of these fractions and represented 8 to 95% of the total plasma HCV RNA. Surprisingly, immunoglobulins G and M were also found in the low-density fractions and could be used to purify the HCV RNA-containing particles (lipo-viro-particles [LVP]). Purified LVP were rich in triglycerides; contained at least apolipoprotein B, HCV RNA, and core protein; and appeared as large spherical particles with a diameter of more than 100 nm and with internal structures. Delipidation of these particles resulted in capsid-like structures recognized by anti-HCV core protein antibody. Purified LVP efficiently bind and enter hepatocyte cell lines, while serum or whole-density fractions do not. Binding of these particles was competed out by VLDL and LDL from noninfected donors and was blocked by anti-apolipoprotein B and E antibodies, whereas upregulation of the LDL receptor increased their internalization. These results suggest that the infectivity of LVP is mediated by endogenous proteins rather than by viral components providing a mechanism of escape from the humoral immune response.


Obesity Facts ◽  
2016 ◽  
Vol 9 (2) ◽  
pp. 101-111 ◽  
Author(s):  
Ming-Shyan Lin ◽  
Su-Er Guo ◽  
Huang-Shen Lin ◽  
Jen-Te Hsu ◽  
Yu-Sheng Lin ◽  
...  

Hepatology ◽  
2011 ◽  
Vol 53 (4) ◽  
pp. 1080-1089 ◽  
Author(s):  
Zong-Gen Peng ◽  
Zhi-Yun Zhao ◽  
Yan-Ping Li ◽  
Yu-Ping Wang ◽  
Lan-Hu Hao ◽  
...  

Gut ◽  
2010 ◽  
Vol 60 (5) ◽  
pp. 680-687 ◽  
Author(s):  
S. H. Bridge ◽  
D. A. Sheridan ◽  
D. J. Felmlee ◽  
S. U. Nielsen ◽  
H. C. Thomas ◽  
...  

Hepatology ◽  
2008 ◽  
Vol 47 (5) ◽  
pp. 1437-1445 ◽  
Author(s):  
Yaakov Nahmias ◽  
Jonathan Goldwasser ◽  
Monica Casali ◽  
Daan van Poll ◽  
Takaji Wakita ◽  
...  

2021 ◽  
Vol 17 (9) ◽  
pp. e1009889
Author(s):  
Bei Wang ◽  
Yue Zhu ◽  
Congci Yu ◽  
Chongyang Zhang ◽  
Qing Tang ◽  
...  

Hepatitis C virus (HCV) infection induces the degradation and decreases the secretion of apolipoprotein B (ApoB). Impaired production and secretion of ApoB-containing lipoprotein is associated with an increase in hepatic steatosis. Therefore, HCV infection-induced degradation of ApoB may contribute to hepatic steatosis and decreased lipoprotein secretion, but the mechanism of HCV infection-induced ApoB degradation has not been completely elucidated. In this study, we found that the ApoB level in HCV-infected cells was regulated by proteasome-associated degradation but not autophagic degradation. ApoB was degraded by the 20S proteasome in a ubiquitin-independent manner. HCV induced the oxidation of ApoB via oxidative stress, and oxidized ApoB was recognized by the PSMA5 and PSMA6 subunits of the 20S proteasome for degradation. Further study showed that ApoB was degraded at endoplasmic reticulum (ER)-associated lipid droplets (LDs) and that the retrotranslocation and degradation of ApoB required Derlin-1 but not gp78 or p97. Moreover, we found that knockdown of ApoB before infection increased the cellular lipid content and enhanced HCV assembly. Overexpression of ApoB-50 inhibited lipid accumulation and repressed viral assembly in HCV-infected cells. Our study reveals a novel mechanism of ApoB degradation and lipid accumulation during HCV infection and might suggest new therapeutic strategies for hepatic steatosis.


Sign in / Sign up

Export Citation Format

Share Document